Real-world DAROL data support darolutamide use regardless of comorbidity burden
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Data from a real-world study and the arasec trial are providing evidence for the use of darolutamide in certain patients. The arasec findings appear to offer insight into the treatment's effectiveness in a specific population, possibly including those in the us. The results suggest that darolutamide may be suitable for use regardless of the patient's comorbidity burden.